Fluoroscopy equipment market seen reaching $9.07 billion by 2030

The fluoroscopy equipment market is projected to rise from $7.15 billion in 2026 to $9.07 billion by 2030, driven by real-time imaging demand, AI adoption and replacement of older systems. North America led the market in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - Fluoroscopy equipment is a core tool for real-time imaging in diagnosis and treatment, including orthopedic surgery, implant placement and injections. - Growth in the market points to rising demand for imaging systems that help clinicians guide procedures and visualize movement inside the body. - The forecast suggests hospitals, outpatient centers and imaging providers will keep investing in newer systems as procedure volumes and safety requirements increase.

What happened: - The fluoroscopy equipment market was valued at $6.79 billion in 2025 and is projected to reach $7.15 billion in 2026. - The market is forecast to climb to $9.07 billion by 2030, implying a 6.1% CAGR from 2026 to 2030. - The Business Research Company released the market study on Aug. 7, 2026, in London. - The report also notes North America held the largest market share in 2025, while Asia-Pacific is expected to be the fastest-growing region.

The details: - Growth from 2025 to 2026 reflects a 5.4% CAGR, supported by more interventional procedures, expanded diagnostic imaging infrastructure, orthopedic use and hospital spending on imaging equipment. - Future demand is expected to come from real-time imaging guidance, broader use of AI-powered diagnostic imaging systems, expansion of outpatient surgical centers and replacement of older imaging devices. - Key trends include digital fluoroscopy systems, mobile C-arm imaging, AI-assisted image processing, minimally invasive procedure guidance and efforts to reduce radiation exposure. - Fluoroscopy works by passing X-rays through the body over time to create live video that shows motion in specific organs or body parts. - The technology is used both for diagnosis and during treatment. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available as the sample report. - The full report is available as the full market report.

Between the lines: - Rising gastrointestinal disease burden is a key demand driver because fluoroscopy helps assess swallowing, digestion and bowel function. - The American Cancer Society projected in January 2024 about 26,890 new U.S. stomach cancer cases, including 16,160 in men and 10,730 in women, plus about 10,880 deaths. - The report’s emphasis on AI, mobile systems and radiation reduction signals a market shifting toward more portable, more efficient and safer imaging workflows. - New 2026 report features include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspots infographics and updated graphics and tables.

What’s next: - Market growth is likely to track continued adoption of minimally invasive procedures and replacement cycles for aging imaging equipment. - Asia-Pacific’s growth trajectory suggests more competition and investment opportunities across hospital and outpatient imaging markets in the region. - More vendors are likely to emphasize AI-enabled imaging, digital platforms and lower-radiation systems as purchase criteria evolve.

The bottom line: - Fluoroscopy equipment remains a steadily expanding imaging market, with the next phase of growth tied to AI, procedure guidance and safer real-time diagnostic tools.